New tetracyclic benzofurocoumarin (benzopsoralen) analogues were synthesized and their
inhibitory effect on the growth of tumor cell lines was evaluated. The human tumor cell lines …

New benzopsoralen analogues were synthesized and their inhibitory effect on the growth of
tumourtumour cell lines (MDA MB231 and TCC-SUP) was evaluated. The in vitro antitumour …

Eight psoralens have been evaluated for their ability to inhibit the in vitro growth of three
human tumor cell lines representing different tumor types, MCF-7 (breast cancer), NCI-H460 …

The synthesis of five new tetracyclic benzofurocoumarin (benzopsoralen) analogues is
described. Their inhibitory effects on the growth of three human tumor cell lines (MDA MB …

Furanocoumarins have been shown to inhibit CYP3A4 in vitro with varying degrees of
potency [Pharmacogenetics1997, 7, 391–396; Chem. Res. Toxicol. 1998, 11, 252–259; …

The synthesis of five new tetracyclic benzopsoralen analogues, compounds 2–6, with 9H‐
xanthen‐9‐one or 9H‐carbazole frameworks, is described. Their inhibitory effects on the …

The development of new prostate cancer protein receptor cytochrome P450 17A1 inhibitors
offers the possibility of generating structures of increased potency. To this end, the chalcone …

In this review we summarize the structure and biological effects of linear and angular
psoralens. These compounds exhibit very interesting biological effects on cell cycle …

Phortress is an anticancer prodrug, which has active metabolite (5F-203) being potent
agonist of the aryl hydrocarbon receptor (AhR). The 5F-203 switches on cytochrome P450 …

Abstract Furobenzoxazin‐3‐one, a new tricyclic nucleus, was synthesised in two different
and straightforward routes: the first route consisted of condensing a furan ring onto a …